Phlecs BV
  • Link to LinkedIn
  • Link to Mail
  • Home
  • Phlecs Blue LED Therapy
    • About Blue LED Therapy
    • Phlecs Devices
    • FAQ
    • UV Fluorescent Lamp EU BAN
  • Home Phototherapy
  • Blue light potential
  • Inflammatory skin conditions
  • Clinical research
    • Blue Light safety and mechanisms of action
    • Inflammatory skin diseases
    • Other potential indications
  • About us
    • The story behind Phlecs
    • Meet the team
    • Contact
  • News
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Blue light exposure decreases systolic blood pressure, arterial stiffness, and improves endothelial function in humans

August 12, 2019/in Clinical Study/by Randy

Whole body irradiation with visible blue light at real world doses improves blood pressure, endothelial function and arterial stiffness by nitric oxide released from photolabile intracutanous nitric oxide metabolites into circulating blood.

View abstract

0 0 Randy https://www.phlecs.com/wp-content/uploads/2023/06/Phlecs-logo.png Randy2019-08-12 11:58:202019-08-12 11:58:20Blue light exposure decreases systolic blood pressure, arterial stiffness, and improves endothelial function in humans

Latest News

  • Phlecs closes funding round for launch of next-generation home-use phototherapy in EuropeNovember 8, 2026 - 11:56 am

    Vlissingen, The Netherlands – November 4, 2026 – Phlecs Light & Health has successfully closed a new funding round to accelerate the development and commercialization of its next-generation home-use phototherapy solution. In the Netherlands, more than 800,000 patients suffer from eczema and psoriasis. Our innovative blue light therapy offers an effective, safe, and convenient treatment […]

  • Phlecs announces a clinical breakthrough in treatment of eczema and secures a grant to develop itsnext-generation deviceJune 2, 2025 - 6:18 pm

    Terneuzen, Nederland29 May 2025 On May 1, 2025, a new study from the Dermatology Clinic in Bad Bentheim, Germany, was presented at the German Dermatology Congress (DDG) in Berlin (abstract in German under number FV02/07 at: https://onlinelibrary.wiley.com/doi/10.1111/ddg.15782_g ). In this prospective pilot study, 150 patients with moderate to severe atopic dermatitis were randomized into three […]

  • Phlecs presents two significant clinical studies demonstrating the effectiveness of its technology in supporting patients with eczema and long COVID.December 3, 2024 - 6:18 pm

    Terneuzen, the NetherlandsDecember 3, 2024 The Medical University of Lodz, Poland’s largest public medical university, recently conducted two studies confirming that full-body blue light therapy is a safe and effective treatment for patients with eczema and post-COVID chronic fatigue. David Aubert, CEO, and Co-founder of Phlecs, commented on these promising results, stating, “These findings are […]

  • Recent clinical findings to aid individuals with eczema and enhance their emotional well-beingSeptember 12, 2023 - 11:22 am

    On World Atopic Eczema Day, Phlecs presents an innovative treatment approach aimed at addressing both the skin condition and the emotional well-being of patients. 

Phlecs

Edisonweg 41
4382 NV Vlissingen

The Netherlands

Pages

  • About Blue LED Therapy
  • Blue LED Therapy Devices
  • Blue light potential
  • Clinical research
    • Blue Light safety and mechanisms of action
    • Inflammatory skin diseases
    • Other potential indications
  • Contact
  • Faq
  • Home
  • Home Phototherapy
  • Inflammatory skin conditions
  • Meet the team
  • News
  • The story behind Phlecs
  • Treatment centers

Latest News

  • Phlecs closes funding round for launch of next-generation home-use phototherapy in EuropeNovember 8, 2026 - 11:56 am
  • Phlecs announces a clinical breakthrough in treatment of eczema and secures a grant to develop itsnext-generation deviceJune 2, 2025 - 6:18 pm
  • Phlecs presents two significant clinical studies demonstrating the effectiveness of its technology in supporting patients with eczema and long COVID.December 3, 2024 - 6:18 pm
© Copyright - Phlecs BV - created by Code Fairies
  • Link to LinkedIn
  • Link to Mail
Link to: Neonatal Phototherapy: A Novel Therapy to Prevent Allergic Skin Disease for At Least 5 Years Link to: Neonatal Phototherapy: A Novel Therapy to Prevent Allergic Skin Disease for At Least 5 Years Neonatal Phototherapy: A Novel Therapy to Prevent Allergic Skin Disease for... Link to: Ease and efficacy in psoriasis treatment Link to: Ease and efficacy in psoriasis treatment Ease and efficacy in psoriasis treatment
Scroll to top Scroll to top Scroll to top